Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Analysts' Corner
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, January 6, 2014 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Express Scripts Holding Company (NASDAQ: ESRX), Pharmacyclics Inc. (NASDAQ: PCYC), WellPoint Inc. (NYSE: WLP), Stryker Corp. (NYSE: SYK), and Zoetis Inc. (NYSE: ZTS). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Express Scripts Holding Company Research Report
On December 20, 2013, Express Scripts Holding Company (Express Scripts) announced its plan to release its Q4 2013 earnings and 2014 earnings guidance on February 20, 2014 after the closing of market. The Company informed that it has scheduled an investor day meeting in New York City at 8:00 a.m. ET on February 21, 2014, in which its senior management will review the strategies to deliver long-term growth and enhance shareholder value, in addition to discussing Q4 2013 earnings and 2014 earnings guidance. Express Scripts added that the presentation can be accessed on the Investor Relations section of the Company website. The Full Research Report on Express Scripts Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Pharmacyclics Inc. Research Report
On December 31, 2013, Pharmacyclics Inc.'s (Pharmacyclics) stock declined 1.46%, ending the day at $105.78. Over the previous three trading sessions, shares of Pharmacyclics lost 2.11%, compared to the Nasdaq Composite which increased 0.23% during the same period. The Full Research Report on Pharmacyclics Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
WellPoint Inc. Research Report
On December 31, 2013, WellPoint Inc.'s (WellPoint) stock rose 0.95%, ending the day at $92.39. Over the previous three trading sessions, shares of WellPoint increased 0.26%, compared to the Dow Jones Industrial Average which rose 0.59% during the same period. The Full Research Report on WellPoint Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Stryker Corp. Research Report
On December 31, 2013, Stryker Corp. (Stryker) announced a definitive agreement to acquire Patient Safety Technologies, Inc. (Patient Safety Technologies) for $2.22 per share, at aggregate purchase price of $120 million. The Company stated that proprietary Safety-Sponge® System and SurgiCount 360(TM) compliance software of SurgiCount Medical, Inc., a wholly-owned subsidiary of Patient Safety Technologies, help to prevent Retained Foreign Objects (RFOs) in the operating room, resulting in improved patient safety and reduced healthcare costs. Stryker added that the Safety-Sponge System will become part of the Company's Instruments division's offerings and will augment its Instruments' broad portfolio of products. Timothy J. Scannell, Group President, MedSurg and Neurotechnology, Stryker, commented, "This acquisition aligns with Stryker's focus on offering products and services that have demonstrated cost effectiveness and clinical outcomes." The Company stated that the transaction is subject to customary closing conditions including approval by the stockholders of Patient Safety Technologies and the expiration or termination of the Hart-Scott-Rodino Antitrust Improvements Act waiting period, and is expected to close in Q1 2014. The Full Research Report on Stryker Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Zoetis Inc. Research Report
On December 20, 2013, Zoetis Inc. (Zoetis) announced that the Company will host a webcast and conference call at 8:30 a.m. EST on February 11, 2014. Zoetis added that CEO Juan Ramón Alaix and Executive Vice President and CFO Rick Passov will review Q4 2013 and full-year 2013 financial results, discuss 2014 financial guidance, and take questions from financial analysts during the call. The Full Research Report on Zoetis Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.http://www.AnalystsCorner.com
©2012 PR Newswire. All Rights Reserved.